|
A more recent version of this article appeared on December 1, 2007
Papers In Press, published online ahead of print September 22, 2007
J. Lipid Res., doi:10.1194/jlr.M700176-JLR200
Submitted on April 10, 2007
Revised on September 19, 2007
Accepted on September 21, 2007
Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease
Sander I. van Leuven, Rachel Hezemans, Johannes H. M. Levels, Susanne Snoek, Pieter C. Stokkers, G. Kees Hovingh, John J. P. Kastelein, Erik S. Stroes, Eric de Groot, and Daan W. Hommes
Vascular Medicine, Academic Medical Centre, Amsterdam 1105 AZ
Corresponding Author: s.i.vanleuven{at}amc.uva.nl
Background: A chronic inflammatory state is a risk factor for accelerated atherogenesis. The aim of our study was to explore whether Crohns disease (CD), characterized by recurrent inflammatory episodes, is also associated with accelerated atherogenesis. Methods: In 60 CD patients and 122 matched controls, carotid intima media thickness (IMT), a validated marker for the burden and progression of atherosclerosis, was assessed ultrasonographically. Additional subgroup analyses including plasma levels of acute phase reactants and HDL protein profiling were performed in 11 consecutive patients with CD in remission, 10 patients with active CD and 15 healthy controls. Results: Carotid IMT in patients with CD was increased compared to healthy volunteers; 0.71 (0.17) versus 0.59 (0.14) mm (p<0.0001), respectively. In the subgroup analysis, HDL levels in controls and patients in remission were identical ((1.45 (0.48) and 1.40 (0.46)mmol/L: p=0.797), whereas HDL during exacerbation was profoundly reduced; 1.02 (0.33): p=0.022. HDL from patients with active CD and CD patients in remission was characterized by a reduced ability to attenuate oxidation compared to controls (p=0.008 and p=0.024 respectively). Conclusions: Patients with CD have increased IMT compared to matched controls, indicative of accelerated atherogenesis. The changes during CD exacerbation in terms of both HDL concentration as well as composition imply a role for impaired HDL protection in these patients.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|